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Rhodiola rosea, a medicinal plant with demonstrated adaptogenic properties, has recently
been reported to contain active compounds with antimicrobial activity. The goal of this
study was to measure the antiviral and antibacterial properties of the bioactive metabolites
of Rhodiola rosea in the serum of experienced marathon runners following supplemen-
tation. Marathon runners, randomly divided into two groups, ingested 600mg/day of
Rhodiola rosea (n=24, 6 female, 18 male) or placebo (n=24, 7 females, 17 males)
for 30 days prior to, the day of, and 7days post-marathon. Blood serum samples were
collected the day before, 15min post-, and 1.5 h post-marathon. Serum from Rhodiola
rosea-supplemented runners collected after marathon running did not attenuate the
marathon-induced susceptibility of HeLa cells to killing by vesicular stomatitis virus.
However, the use of Rhodiola rosea induced antiviral activity at early times post-infection
by delaying an exercise-dependent increase in virus replication (P=0.013 compared to
placebo). Serum from both groups collected 15min post-marathon significantly promoted
the growth of Escherichia coli in culture as compared to serum collected the day before
the marathon (P=0.003, all subjects). Furthermore, the serum from subjects ingesting
Rhodiola rosea did not display antibacterial properties at any time point as indicated by
a lack of group differences immediately (P=0.785) or 1.5 h (P=0.633) post-marathon.
These results indicate that bioactive compounds in the serum of subjects ingesting
Rhodiola roseamay exert protective effects against virus replication following intense and
prolonged exercise by inducing antiviral activity.
Keywords: Rhodiola rosea, physical activity, vesicular stomatitis virus, Escherichia coli, Staphylococcus aureus,
bacterial growth
Introduction
Rhodiola rosea (also known as golden root, rose root, Arctic root) is a perennial herbaceous
plant in the Crassulaceae family found at high altitudes in the Arctic and mountainous regions
throughout Europe and Asia (1). It has historically been used to treat a range of conditions,
including fatigue, depression and anxiety, impotence, and nervous system disorders (1). Rhodiola
rosea has also received attention for its potential adaptogenic and ergogenic properties including the
enhancement of physical and mental performance and reduction of fatigue (2, 3). More recently,
Rhodiola rosea and polyphenolic bioactive compounds from the plant, such as rosavin, salidroside,
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syringin, triandrin, and tyrosol, have been reported to exert ben-
eficial effects against several pathogens. For example, flavonoids
isolated from the roots of Rhodiola rosea have been shown to
inhibit the activity of neuraminidases from Clostridium perfrin-
gens and influenza virus, and exert anti-influenza virus activ-
ities in vitro (4). Salidroside, a major bioactive component of
Rhodiola rosea has been reported to modulate the expression of
antiviral cytokines, such as IFNγ, and TNFα, and inhibit the
replication of coxsackievirus B3 perhaps through modulation of
oxidative stress (5, 6). More recently, studies have shown that
Rhodiola inhibits dengue virus multiplication by regulating the
innate immune response genes, RIG-I, MDA5, and ISG, to pro-
mote an effective antiviral immune response (7). Taken together,
these data highlight the antiviral capacity of Rhodiola rosea and its
potential as a therapeutic strategy against a variety of infectious
diseases.
Although in vitro studies have yielded promising results, the
antimicrobial capacity of Rhodiola species in humans has not
been evaluated. The purpose of this study was to measure the
antiviral and antibacterial activity in the serum of athletes ingest-
ing Rhodiola rosea or placebo for 30 days prior to participat-
ing in a competitive marathon. This work is an extension of a
study investigating the adaptogenic potential of Rhodiola Rosea
in experienced runners completing a marathon (8). Shanely et al.
reported that ingesting Rhodiola Rosea supplements for 30 days
prior to marathon running did not reduce the muscle damage and
inflammation generated by strenuous exercise. Intense endurance
exercise, including marathon-type exertion, is known to induce
deleterious changes in the immune system. During strenuous
exercise, there is a substantial increase in reactive oxygen species
(ROS) production resulting in oxidative stress, structural damage
to the skeletal muscle fiber ultrastructure, inflammation, and
transient immune dysfunction (9). Transient immunosuppres-
sion induced by prolonged, intense exercise is associated with
increased incidence and severity of acute respiratory infections.
Studies have observed decreased salivary IgA levels and natural
killer (NK) cell function in endurance athletes, both of which
offer protection against respiratory viruses, such as influenza
virus and rhinoviruses (10–12). Therefore, there is great interest
in determining efficacious countermeasures for athletes in order
to reduce the risk of acquiring infections following strenuous
exercise.
There are limitations to measuring the anti-pathogenic effects
of therapeutics in human subjects due to ethical constraints.
Because of this, we have developed in vitro assays to eval-
uate the ability of serum from supplemented individuals to
inhibit the growth of bacteria, and the replication and cyto-
pathic effects (CPE) associated with virus infections, ex vivo. Our
previous studies using these techniques have yielded consistent
and reproducible results allowing us to carry out human stud-
ies safely and non-invasively (13). In this study, we determined
that Rhodiola rosea suppresses an exercise-induced increase in
virus replication, but has no effect on the growth of the bac-
teria, Escherichia coli (E. coli) and Staphylococcus aureus (S.
aureus). Consistent with previous reports, our data demonstrate
that Rhodiola rosea contains compounds that act as antiviral
agents.
Materials and Methods
Subjects
The details of the subjects and research design associated with this
study have been previously published (8). The subjects partici-
pated in the Thunder Road Marathon on November 17, 2012 in
Charlotte, NC, USA. Of the 55 volunteers, 48 runners completed
all aspects of the study. Subjects were trained competitive run-
ners with a marathon personal record of 4.5 h or less within the
last 1.5 years, 25–65 years of age, and willing to avoid the use of
additional supplements or medications known to affect inflam-
mation. All study procedures were reviewed and approved by the
Appalachian State University Institutional Review Board (IRB).
Study Design
Rhodiola rosea root extract was prepared by PoliNat SL (Las Pal-
mas, Spain). Rhodiola rosea roots were obtained and prepared into
powder by trained personnel in Siberia. The powder was trans-
ported to PoliNat manufacturing facilities in Las Palmas, Spain
within 6weeks. The bioactive content of the Rhodiola rosea pow-
der was determined by high-performance liquid chromatography
and extracted using a water:ethanol process. The final dried prod-
uct was subjected to liquid chromatography for determination of
the concentration of bioactive compounds. Results revealed a total
rosavins content of>5% and salidroside>1.8%.
Subjects received Rhodiola rosea extract or placebo capsules
(prepared and supplied by PL Thomas & Co., Inc., Morristown,
NJ, USA) in a randomized, double-blind study. Each Rhodiola
rosea capsule contained 300mg of Rhodiola Rosea extract
containing 5.2% bioactives (11.3mg of rosavins and 4.3mg of
salidroside). Each placebo capsule contained 300mg cornstarch.
Subjects ingested two capsules daily, one in the morning before
breakfast and one in the evening before dinner for 30 days prior
to the marathon, the day of the marathon, and for 7 days after
the marathon. Blood samples were collected between 9:30 and
1:00 p.m. the day before the marathon, 2–15min post-marathon,
and 1.5 h post-marathon (Figure 1). Serum collected from the
blood was aliquoted, snap frozen in liquid nitrogen, and stored at
 80°C until use.
The Rhodiola rosea and placebo group did not differ signifi-
cantly in age (40.3 1.44 and 43.9 1.23, respectively, P= 0.141).
FIGURE 1 | Research design. Randomized runners ingested Rhodiola rosea
(N= 24) or placebo (N=24) for 30 days prior to the marathon, the day of the
marathon, and for 7 days after the marathon. Blood samples were collected
the day before the marathon (pre-race), approximately 15min post-marathon,
and 1.5 h post-marathon. Serum collected from the blood was stored at
 80°C until use.
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Additional subject characteristics, such as weight, BMI, body
fat, and marathon time, also did not differ significantly between
groups (8).
Cells and Virus
HeLa cervical cancer cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 7.5% fetal bovine serum
(FBS). Vesicular stomatitis virus (VSV) is a prototype of negative-
strand RNA viruses, such as rabies and influenza viruses. It is
highly cytopathic for cells from a variety of different species,
including neurons and respiratory epithelial cells, thusmaking it a
desirable model for the study of pathogenic viruses (14). Recom-
binant wild-type VSV (rwt virus) contains genes from several wt
strains of VSV. Rwt virus and recombinant VSV expressing EGFP
(green fluorescent protein) as a foreign gene (rwt-GFP virus) have
been described previously (15). Virus stocks were prepared in
HeLa cells using methods described previously (16). For all virus
infections, HeLa cells were infected in DMEM with 7.5% FBS at a
multiplicity of infection (MOI) of 3 PFU/cell.
Antiviral Activity
The ability ofVSV to kill permissive cells in the presence of various
concentrations of serum was measured in order to assess the
antiviral properties in serum samples from Rhodiola rosea and
placebo subjects. Specifically, serum samples at each time point
were heat-inactivated for 30min at 56°C (HI-serum) to prevent
the complication of complement-mediated cell lysis. HeLa cells,
susceptible to infection by VSV, were grown in 96-well dishes (in
DMEM plus 7.5% FBS) until they reached approximately 70–80%
confluency. At this time, cells were incubated with HI-serum at a
serum to media ratio of 1:2. At various times post-incubation (0
and 4 h), cells were infected with rwt virus at a MOI of 3 PFU/cell.
Cells were assessed for viability using MTT assay (MTT Cell Pro-
liferation Kit, Roche Diagnostics) at 24 and 48 h post-infection.
Controls included incubation of cells with serum alone (serum-
alone samples) tomeasure potential cytotoxic effects of the serum,
virus alone (virus-alone samples) to determine the cytotoxic effect
of virus, and untreated and uninfected cells (mock) as background
controls. Data were quantitated by dividing the values obtained
from each sample by the mock value. All data were then normal-
ized to the serum-alone data to adjust for differences in the serum
responses between subjects. These values were then normalized
to the pre-race values in order to more clearly observe changes
following exercise and recovery periods.
Virus Replication
To determine the effect of serum from test subjects on the repli-
cation capacity of VSV, HeLa cells were grown in six-well dishes
until they reached 70–80% confluency. As described above, cells
were incubated with HI-serum at a serum tomedia ratio of 1:2. At
4 h post-incubation, cells were infected with rwt-GFP at an MOI
of 3 PFU/cell. At 6 and 12 h post-infection, cells were washed, har-
vested in phosphate buffered saline (PBS), and subjected to flow
cytometry to measure the fluorescence of GFP within cells. Two
parameters were measured: (1) The percentage of cells expressing
GFP, as an indication of the number of cells supporting virus
replication, and (2) the geometric mean fluorescence, measuring
the degree of replication within cells. All data were normalized to
the pre-race values.
Antibacterial Activity
Serum samples from Rhodiola rosea and placebo supplemented
subjects were tested for their effect on the growth of select bac-
teria. HI-serum samples were diluted at a 1:2 ratio with LB
bacterial nutrient broth (Fisher Scientific) and incubated with
20μl of overnight cultures of Escherichia coli (E. coli) strain
K-12 or coagulase-positive Staphylococcus aureus (S. aureus), a
BSL2 pathogen, both obtained from Carolina Biological Supply
Company (Burlington,NC,USA). Controls included serum-alone
samples, bacteria-alone samples (growth control), nutrient broth
samples (sterility control), and bacteria grown in the presence
of 128μg/ml of ampicillin (obtained from Fischer Scientific). All
experimental and control cultures were incubated at 37°C for 24 h,
at which time samples were carefully re-suspended, transferred to
a 96-well dish, and absorbance readings at 600 nmwere measured
(Molecular Devices SoftMax Pro 5 microplate reader). Data were
quantitated by dividing the experimental samples (experimental
minus serum-alone) by the growth control samples (growth con-
trolminus sterility control). Asmentioned previously, these values
were then normalized to the pre-race values.
Statistical Methods
Serum from male and female runners was combined for data
analysis due to similarities in race time, muscle function, and
inflammatory effects (8). All data are expressed as mean SE.
Data were compared between groups at the two post-race time
points using Student’s t-test, with comparisons between time
points within a group compared using paired t-tests. After Bon-
feronni adjustment, statistical significance was set at P< 0.025,
with trends noted atP< 0.05. RepeatedmeasuresANOVAwas not
used since all data were normalized to pre-race values to adjust for
differences in responses between subjects.
Results
Antiviral Effects of Rhodiola rosea
Supplementation
In order to measure the antiviral activity in serum from Rhodiola
rosea and placebo supplemented individuals, we exposed HeLa
cells to serum from marathon runners collected pre- and post-
marathon and evaluated the ability of serum samples to protect
cells against killing by VSV. Results show that there was no dif-
ference in the effect of serum alone from Rhodiola rosea versus
placebo-supplemented subjects on HeLa cell viability at any time
(Figure 2A). Furthermore, there was a significant increase in cell
viability following exercise in both sample groups (15min and
1.5 h post-race, P< 0.025). These data demonstrate that serum
from subjects did not exert any cytotoxic effects on HeLa cells
and that there were no group differences in cell viability. To
measure the effect of serum on the viability of cells following
virus infection, data were normalized to serum-alone samples and
expressed relative to the pre-race values. Results in Figure 2B
indicate that HeLa cells were more susceptible to killing by VSV
when they were exposed to serum obtained from subjects after
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FIGURE 2 | Antiviral activity in the serum from test subjects. HeLa
cells were infected with serum from Rhodiola rosea or placebo-
supplemented subjects for different times and infected with rwt virus.
Cell viability was measured by MTT assay. Controls included cells
infected with virus alone or incubated with serum alone. All data were
normalized to mock-infected cells. (A) Impact of serum alone on viability
of HeLa cells (24 h). (B,C). Cells were incubated with serum from
subjects for 0 h (B) or 4 h (C), followed by VSV infection (rwt virus) for
24 h. Data were normalized to mock-infected cells and expressed
relative to the pre-race values. Data are expressed as meanSE.
*indicates significant differences relative to pre-race values (P<0.025).
indicates P<0.05.
the marathon (5–7% decrease in cell viability, P< 0.05). This was
apparent when cells were experimentally incubated with serum
and virus at the same time (0 h). However, when cells were incu-
bated with serum for 4 h prior to virus infection, we did not
observe a decrease in HeLa cell viability (Figure 2C). In addition,
serum from subjects who ingested Rhodiola rosea did not protect
cells from the exercise-induced susceptibility to killing by rwt
virus, as indicated by the lack of difference in cell viability between
the two groups.
Effect of Rhodiola rosea Supplementation on
Virus Replication
Although we did not observe any effect of supplementation on
the ability of serum to protect cells from killing by VSV after
completing a marathon, it is possible that the early effects of
virus infection, such as steps in the viral replication cycle, were
influenced by Rhodiola rosea. To measure the effects of Rhodiola
rosea-supplemented serum on virus replication, HeLa cells were
incubated with serum from subjects for 4 h prior to infection to
allow cells to initiate cellular responses. Cells were then infected
with an rwt virus strain engineered to express green fluorescent
protein (rwt-GFP) during its replication cycle (15). Although
not significant, a lower percentage of cells expressed GFP at 6 h
post-infection when incubated with the 15min post-race serum
obtained fromRhodiola rosea versus placebo subjects (Figure 3A).
This trend was not observed by 12 h post-infection (Figure 3B).
Consistent with this result, at 12 h post-infection, the geometric
mean fluorescence was significantly lower in cells exposed to the
15min post-race serum from Rhodiola rosea-supplemented indi-
viduals as compared to serum from placebo subjects (P= 0.013)
(Figure 3D). This difference was not observed at 6 h post-
infection (Figure 3C). These results indicate that Rhodiola rosea
delayed virus infection immediately after themarathon. Although
virus recovered its ability to infect cells in culture by 12 h post-
infection (Figure 3B), the degree of replication within cells was
significantly lower during that time, as indicated by the geometric
mean fluorescence data in Figure 3D.
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FIGURE 3 | Replication of VSV in HeLa cells in the presence of serum
from Rhodiola rosea or placebo-supplemented subjects. HeLa cells were
incubated with serum from Rhodiola rosea or placebo subjects for 4 h and
infected with rwt-GFP virus. At 6 or 12 h post-infection, GFP expression was
measured by flow cytometry. Data were expressed as the percentage of cells
expressing GFP at 6 h (A) or 12 h (B) and the geometric mean fluorescence at
6 h (C) and 12 h (D). All results were normalized to mock-samples and
expressed relative to the pre-race values. Data are expressed as meanSE.
Data were compared between groups at each time point using Student’s t-test.
P<0.025 was considered statistically significant.
Effect of Rhodiola rosea on Growth of Bacteria
To determine the antibacterial effects of Rhodiola rosea, the effect
of serum on the growth of the pathogenic bacteria, E. coli and
S. aureus, was evaluated. Our results in Figure 4A show a sig-
nificant exercise-induced increase in bacterial growth of E. coli
in the Rhodiola rosea (16.8% increase, P= 0.018) group, as well
as an increasing trend in the placebo (14.2% increase, P= 0.052)
group, which decreased during the recovery period. Additionally,
there were no significant group differences in the growth of E.
coli (Figure 4A) or S. aureus (Figure 4B) 15min or 1.5 h post-
marathon. These data indicate that intense and prolonged exercise
leads to increased susceptibility to bacterial infection, which is not
improved by ingesting Rhodiola rosea.
Discussion
Our results indicate that Rhodiola rosea supplementation has the
potential to protect athletes from exercise-induced susceptibility
to infections by attenuating virus replication. Studies have shown
that an aqueous extract derived from the rhizome of Rhodiola
imbricata induces the expression of the innate immune response
genes, RIG-I and MDA5, in response to infection with dengue
virus (7). RIG-I and MDA5 are cytoplasmic DEx (D/H) box
helicases that function as pattern recognition receptors for the
detection of intracellular viral products, such as viral nucleic acids,
leading to the expression of type I interferons (IFN-α/β) (17, 18).
Type I IFNs secreted from infected cells bind to the IFNα receptor
(IFNAR) on surrounding cells to initiate transcription of IFN-
stimulated genes with antiviral functions. Two key components
of IFN-mediated action against viruses are 20,50-oligoadenylate
synthetase (20,50-OAS) and MxA, which inhibit viral replication
by inducing viral RNA degradation and inhibiting spread (19).
RIG-I responds to a variety of positive and negative strand RNA
viruses, including VSV (20). Therefore, it is possible that Rhodiola
rosea regulates the antiviral response in infected cells in a manner
similar to Rhodiola imbricata and this effect may be responsible
for the decrease in virus replication that we observed when cells
were incubated with serum from Rhodiola rosea versus placebo
subjects. Future studies will investigate the effect of Rhodiola rosea
extracts and supplementation on type I IFN induction by innate
immune receptors and downstream effects on IFN signaling
pathways.
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FIGURE 4 | Growth of bacteria in the presence of serum from
Rhodiola rosea versus placebo-supplemented subjects. E. coli (A) or
S. aureus (B) was incubated with Rhodiola rosea or placebo serum for
24 h. Growth of bacteria was determined by measuring absorbance
readings at 600 nm. All readings were normalized to the pre-race
supplementation values. Data are expressed as meanSE. Time-points
within a group were compared using paired t-test. P<0.025 was
considered statistically significant.
We did not observe a significant effect of Rhodiola rosea on
the ability of cells to delay the CPE associated with VSV infec-
tion in vitro. In our study, cells were infected synchronously
with a wild-type (wt) strain of VSV expressing the viral matrix
(M) protein. M protein inhibits host gene expression in infected
cells resulting in the suppression of the cellular antiviral immune
response (20). Therefore, Rhodiola rosea supplementation may
have successfully delayed the early steps of the replication cycle
of VSV in infected HeLa cells by inducing expression of antiviral
factors, but the VSV M protein may have ultimately suppressed
the beneficial effect of Rhodiola rosea by shutting off expression of
antiviral genes. In support of this hypothesis, studies have reported
that the inhibition of host gene expression by M protein in HeLa
cells leads to cellular damage and stress resulting in the accel-
eration of cell death via the mitochondrial (intrinsic) apoptotic
pathway (21, 22). It is possible that exposure of cells to a lower
concentration of virus in our study would allow serum factors
from Rhodiola rosea-supplemented subjects to have the opportu-
nity to induce a more robust antiviral response and attenuate the
replication and spread of VSV. Furthermore, Rhodiola rosea may
exert more beneficial effects during natural viral infections, where
cells would be exposed to lower levels of virus particles than those
artificially administered in our cell culture study.
Limited studies have investigated the effect of Rhodiola rosea
and extracts from Rhodiola rosea on infections by bacterial
pathogens. Cybulska et al. reported that Rhodiola rosea extracts
containing salidroside and rosavin demonstrated some inhibitory
activity against Neisseria Ghonorrhea isolates with different
antimicrobial resistance phenotypes (23). Although this study
highlights a potential inhibitory effect of Rhodiola species on bac-
terial infections, in our study, serum from subjects ingesting Rho-
diola rosea-collected post-marathon failed to suppress the growth
of both E. coli and S. aureus in culture. In fact, marathon running
stimulated the growth of E. coli in both placebo andRhodiola rosea
groups. These results are similar to our recent findings in which
serum from athletes ingesting a blueberry–green tea–polyphenol
soy protein complex (PSPC) promoted the growth of both E. coli
and S. aureus similarly to the placebo group following a 3-day
intensified training period (13). Interestingly, polyphenolic tea
catechins are effective in decreasing expression of bacterial vir-
ulence factors, such as those responsible for biofilm formation
and motility (24). Therefore, it is possible that salidroside and
other phenolic compounds from Rhodiola rosea-supplemented
subjects exert antibacterial effects that were not measured in
our study, such as biofilm formation or changes at the level of
gene expression. In support of this hypothesis, salidroside from
Rhodiola crenulata was shown to be an active compound respon-
sible for preventing Propionibacterium acnes biofilm formation
in vitro (25). Additionally, since we did not measure the levels
of polyphenols in the circulation at any time during our study, it
is possible that levels of the active compounds in Rhodiola rosea
may be below theminimum inhibitor concentration (MIC) for the
bacteria tested in our study. Because studies have indicated that
Rhodiola induces cellular changes that are antiviral in nature, it is
likely that viruses and other intracellular pathogens may be more
susceptible to the effects of Rhodiola rosea supplementation than
extracellular pathogens. From a practical viewpoint, endurance
athletes are prone to acute viral illnesses following heavy exertion,
making the antiviral effects of Rhodiola rosea more applicable to
the athletic condition.
During strenuous exercise, there is a substantial increase in
ROS, which is not only associated with cell and tissue destruction,
but with the regulation of immune responses at the level of both T
cells and antigen-presenting cells (26). Oxidative stress and exces-
sive production of superoxides has also been found to enhance
infections associated with a variety of different viruses and pro-
mote tissue damage, perhaps by activation of the transcription
factor NF-kβ leading to enhanced inflammation and apoptosis
of infected cells (27). Therefore, naturally occurring nutritional
sources of antioxidants containing polyphenolic compounds have
the potential to an attenuate oxidative damage by acting as ROS
scavengers, metal chelators, and enzyme modulators (26, 28). It
is intriguing to consider that polyphenols in Rhodiola rosea may
decrease the risk of acquiring virus infections following rigorous
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exercise by inhibiting oxidative stress. However, Shanely et al.
showed that supplementation of our subject group with Rhodiola
rosea did not lead to changes in the expression of extracellular
heat shock protein (HSP) 72, a marker of oxidative stress, or the
levels of inflammatory cytokines followingmarathon running (8).
Therefore, it is possible that alternativemechanisms, such as those
at the cellular level, may be responsible for the attenuation of virus
replication that we observed in this study. Our future studies will
be aimed at determining the molecular mechanisms by which
Rhodiola rosea induces antiviral activity in athletes.
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